MCID: CPP003
MIFTS: 35

Cap Polyposis malady

Categories: Gastrointestinal diseases, Rare diseases

Aliases & Classifications for Cap Polyposis

About this section
Sources:
31ICD10 via Orphanet, 54Orphanet
See all MalaCards sources

Aliases & Descriptions for Cap Polyposis:

Name: Cap Polyposis 54
Inflammatory Myoglandular Polyps 54
Eroded Polypoid Hyperplasia 54
 
Cap Inflammatory Polyposis 54
Polypoid Prolapsing Folds 54

Characteristics:

Orphanet epidemiological data:

54
inflammatory myoglandular polyps:
Inheritance: Not applicable; Prevalence: <1/1000000 (Worldwide); Age of onset: Adolescent,Adult,Childhood,Elderly

Classifications:



External Ids:

Orphanet54 ORPHA160148
ICD10 via Orphanet31 D12.6

Summaries for Cap Polyposis

About this section
MalaCards based summary: Cap Polyposis, also known as inflammatory myoglandular polyps, is related to choroid epithelioid cell melanoma and trophoblastic neoplasm, and has symptoms including Array, Array and Array. An important gene associated with Cap Polyposis is ALB (Albumin), and among its related pathways are CLEC7A (Dectin-1) signaling and Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS). Affiliated tissues include colon.

Related Diseases for Cap Polyposis

About this section

Diseases related to Cap Polyposis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 49)
idRelated DiseaseScoreTop Affiliating Genes
1choroid epithelioid cell melanoma10.1MUC2, MUC5AC
2trophoblastic neoplasm10.1MUC2, MUC5AC
3strabismus10.1MUC2, MUC5AC
4papillary adenofibroma10.1MUC2, MUC5AC
5sagittal sinus thrombosis10.1MUC2, MUC5AC
6myopathy, lactic acidosis, and sideroblastic anemia 210.1MUC2, MUC5AC
7lateral sinus thrombosis10.1MUC2, MUC5AC
8retina lymphoma10.1MUC2, MUC5AC
9pseudo-meigs syndrome10.1MUC2, MUC5AC
10vaginal villous adenoma10.1MUC2, MUC5AC
11prostate stromal sarcoma10.1MUC2, MUC5AC
12lung clear cell carcinoma10.1MUC2, MUC5AC
13solitary rectal ulcer syndrome10.1
14spastic diplegia infantile type10.1MUC2, MUC5AC
15fallopian tube leiomyosarcoma10.1ALB, MUC2
16acute stress disorder10.1MUC2, MUC5AC
17his bundle tachycardia10.0MUC2, MUC5AC
18basophilic carcinoma10.0MUC2, MUC5AC
19colitis10.0
20protein-losing enteropathy10.0
21spinal muscular atrophy with progressive myoclonic epilepsy10.0MUC2, MUC5AC
22thymus mucoepidermoid carcinoma10.0MUC4, MUC5AC
23acute chest syndrome10.0ALB, MUC5AC
24sarcomatoid mesothelioma10.0MUC2, MUC4
25aicardi-goutieres syndrome10.0MUC2, MUC4
26lymphedema10.0MUC4, MUC5AC
27bladder colonic type adenocarcinoma10.0MUC2, MUC5AC
28proctitis9.9ALB, MUC2
29ulcerative colitis9.9
30porencephaly, cerebellar hypoplasia, and internal malformations9.9ALB, MUC2, MUC5AC
31nephropathy with pretibial epidermolysis bullosa and deafness9.9ALB, MUC2, MUC5AC
32long bones of lower limb cancer9.9MUC4, MUC5AC
33pituitary carcinoma9.9MUC2, MUC4
34pearson syndrome9.9MUC4, MUC5AC
35laryngeal mucoepidermoid carcinoma9.8MUC2, MUC4, MUC5AC
36fibular collateral ligament bursitis9.8MUC2, MUC4, MUC5AC
37refractory plasma cell neoplasm9.8MUC2, MUC4, MUC5AC
38odontotrichoungual-digital-palmar syndrome9.8MUC2, MUC4, MUC5AC
39retrograde amnesia9.8MUC2, MUC4, MUC5AC
40gastroesophageal junction adenocarcinoma9.8MUC2, MUC4, MUC5AC
41crohn's disease9.7
42inflammatory bowel disease9.7
43mucositis9.7
44rectal prolapse9.7
45membranoproliferative glomerulonephritis9.7ALB, MUC2, MUC3A, MUC5AC
46brachydactyly, type b19.6MUC2, MUC3A, MUC4, MUC5AC
47hyperlysinemia9.5MUC2, MUC3A, MUC4, MUC5AC
48basal cell carcinoma 79.5MUC2, MUC4, MUC5AC
49maternally-inherited cardiomyopathy and hearing loss9.4ALB, MUC2, MUC3A, MUC4, MUC5AC

Graphical network of the top 20 diseases related to Cap Polyposis:



Diseases related to cap polyposis

Symptoms & Phenotypes for Cap Polyposis

About this section

Human phenotypes related to Cap Polyposis:

 54 64 (show all 8)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 colorectal polyposis64 54 Obligate (100%) HP:0200063
2 constipation64 54 Very frequent (99-80%) HP:0002019
3 abdominal pain64 54 Very frequent (99-80%) HP:0002027
4 hematochezia64 54 Very frequent (99-80%) HP:0002573
5 chronic atrophic gastritis64 54 Very frequent (99-80%) HP:0002582
6 weight loss64 54 Frequent (79-30%) HP:0001824
7 diarrhea54 Frequent (79-30%)
8 abdominal distention64 54 Frequent (79-30%) HP:0003270

Drugs & Therapeutics for Cap Polyposis

About this section

Drugs for Cap Polyposis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1ColaNutraceuticalPhase 2, Phase 31946
2Omega 3 Fatty AcidNutraceuticalPhase 2, Phase 31018
3
SulindacapprovedPhase 23738194-50-25352, 1548887
Synonyms:
(E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid
2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
32004-68-5
38194-50-2
5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid
53933-60-1
6301-55-9
9000-14-0
AB00513800
AC-4550
AC1L1K5T
AC1LU7GU
AC1LU7GY
AC1Q6YHK
AKOS004119989
AR-1A9609
Aclin
Aflodac
Alphapharm Brand of Sulindac
Apo Sulin
Apo-Sulin
Apotex Brand of Sulindac
Arthrobid
Arthrocine
BB_SC-1128
BPBio1_000315
BRD-A03427350-001-01-3
BRD-A13946108-001-04-9
BRN 2951842
BSPBio_000285
BSPBio_002890
C01531
C20H17FO3S
CAS-38194-50-2
CCRIS 3305
CHEBI:9352
CHEMBL1376
CID1548885
CID1548887
CID5352
CPD000326718
Cahill May Roberts Brand of Sulindac
Chemia Brand of Sulindac
Chibret
Clinoril
Clinoril (TN)
Copal
Copal resin
Copal rosin varnish
Copals
D00120
D013467
DB00605
DivK1c_000601
EINECS 232-527-9
EINECS 250-893-8
EINECS 253-819-2
EINECS 258-873-0
EU-0101070
Gum copal
HMS1568O07
HMS1921C11
HMS2089J04
HMS2092K15
HMS501O03
I06-0523
IDI1_000601
KBio1_000601
KBio2_001506
KBio2_002320
KBio2_004074
KBio2_004888
KBio2_006642
KBio2_007456
KBio3_002110
KBio3_002800
KBioGR_001571
 
KBioGR_002320
KBioSS_001506
KBioSS_002322
KST-1B6530
Kenalin
Kendrick Brand of Sulindac
Klinoril
LS-81610
Lopac-S-8139
Lopac0_001070
MK 231
MK-231
MK231
MLS001056554
MLS001304027
MLS002207124
Merck Brand of Sulindac
Merck Sharp & Dohme Brand of Sulindac
Mobilin
MolPort-002-507-760
MolPort-003-666-287
NCGC00015970-01
NCGC00015970-02
NCGC00015970-03
NCGC00015970-08
NCGC00025268-01
NCGC00025268-02
NCGC00025268-03
NCGC00094349-01
NCGC00094349-02
NINDS_000601
Novo Sundac
Novo-Sundac
Novopharm Brand of Sulindac
Nu Pharm Brand of Sulindac
Nu Sulindac
Nu-Pharm Brand of Sulindac
Nu-Sulindac
Prestwick0_000073
Prestwick1_000073
Prestwick2_000073
Prestwick3_000073
Prestwick_456
Resin copal
S 8139
S2007_Selleck
S4429_SIAL
S8139_SIAL
S8139_SIGMA
SAM002554933
SBB058181
SMR000043852
SMR000326718
SPBio_001451
SPBio_002206
SPECTRUM1500556
STK802068
Spectrum2_001326
Spectrum3_001365
Spectrum4_000876
Spectrum5_001024
Spectrum_001026
Sulindac
Sulindac (JAN/USP/INN)
Sulindac [USAN:BAN:INN:JAN]
Sulindac sulfoxide
Sulindaco
Sulindaco [INN-Spanish]
Sulindacum
Sulindacum [INN-Latin]
Sulindal
Tocris-1707
UNII-184SNS8VUH
UNII-M5221THD3M
UNM-0000306136
Z-5-Fluoro-2-methyl-1-[p-(methlsulfinyl)benzylidene]indene-3-acetic acid
[(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid
cMAP_000021
cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid
cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid
sulindac
{(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
{(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
{5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid
4
Pramipexoleapproved, investigationalPhase 2139104632-26-059868, 119570
Synonyms:
(-)-Pramipexole
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
(6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
(6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
(S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole
(S)-N  6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
104632-26-0
111GE001
2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole
2-amino-6-propylaminotetrahydrobenzothiazole
AC1L3P1T
BIDD:GT0250
C10H17N3S
CHEBI:8356
CHEMBL301265
CID119570
CPD000449298
D05575
DivK1c_006916
Furfuryl Acetate
HMS2051A21
HMS2090C15
KBio1_001860
KBio2_002340
KBio2_004908
 
KBio2_007476
KBioSS_002343
LS-40722
MLS000758250
MLS001423952
Mirapex
MolPort-003-849-957
NCGC00167441-01
Pramipexol
Pramipexol [Spanish]
Pramipexole
Pramipexole (USAN/INN)
Pramipexole 2HCl Monohydrate
Pramipexole [USAN:INN]
Pramipexole hydrochloride
Pramipexolum
Pramipexolum [Latin]
SAM001247006
SBB070477
SMR000449298
SND-919
SUD919CL2Y
SpecPlus_000820
Spectrum5_001453
Spectrum_001838
U-98528E
pramipexole
5
DopamineapprovedPhase 2383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
6
Vitamin Aapproved, nutraceutical, vet_approvedPhase 249211103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
7Analgesics, Non-NarcoticPhase 2, Phase 16501
8Antiparkinson AgentsPhase 21574
9AntioxidantsPhase 23050
10Dopamine AgentsPhase 23836
11Dopamine agonistsPhase 2632
12Protective AgentsPhase 27443
13AnalgesicsPhase 2, Phase 111733
14Anti-Inflammatory Agents, Non-SteroidalPhase 2, Phase 14443
15Neurotransmitter AgentsPhase 218340
16
Erlotinib HydrochloridePhase 2810183319-69-9176871
Synonyms:
 
erlotinib hydrochloride
17Cyclooxygenase InhibitorsPhase 2, Phase 12870
18Antirheumatic AgentsPhase 2, Phase 110956
19Peripheral Nervous System AgentsPhase 2, Phase 123689
20Protein Kinase InhibitorsPhase 23689
21Retinol palmitatePhase 2492
22Anti-Inflammatory AgentsPhase 2, Phase 110729
23
CurcuminPhase 2146458-37-7969516
Synonyms:
1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione
C.I. Natural Yellow 3
CI Natural Yellow 3
Cucurmin
Curcuma
Curcumin
Curcumin I
Diferaloylmethane
Diferuloylmethane
Gelbwurz
Golden seal
Haidr
Halad
Haldar
Halud
Hydrastis
 
Indian saffron
Indian turmeric
Kacha haldi
Kurkumin [czech]
Merita earth
Natural yellow 3
Orange root
Safran D'inde
Souchet
Terra merita
Tumeric yellow
Turmeric
Turmeric (>98% curcurmin)
Turmeric oleoresin (79%-85% curcumin)
Turmeric yellow
Yellow ginger
Yellow puccoon
Yellow root
Yo-kin
Zlut prirodni 3 [Czech]
24Turmeric extractPhase 276
25retinolNutraceuticalPhase 2492
26TurmericNutraceuticalPhase 284
27
Celecoxibapproved, investigationalPhase 1444169590-42-52662
Synonyms:
169590-42-5
184007-95-2
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
AC-4228
AC1L1E6K
AI-525
BIDD:GT0408
BRD-K02637541-001-02-4
BSPBio_003596
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
C07589
C105934
C17H14F3N3O2S
CCRIS 8679
CEL
CEP-33222
CHEBI:41423
CHEMBL118
CID2662
CPD000550473
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
Celecoxib
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxibum
Celocoxib
Célécoxib
D00567
DB00482
DivK1c_000893
Eurocox
FT-0080064
HMS1922G14
HMS2089L18
HMS2093I07
HMS502M15
HSDB 7038
I01-1033
IDI1_000893
KBio1_000893
KBio2_000912
 
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
LS-31667
MLS001165684
MLS001195656
MLS001304708
Medicoxib
MolPort-002-885-815
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCI60_041049
NINDS_000893
NSC719627
Onsenal
P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
Pfizer brand of celecoxib
S1261_Selleck
SAM002589995
SC 58635
SC-58553, SC-58635
SC-58635
SC58635
SMR000550473
SPBio_001512
SPECTRUM1503678
Solexa
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
Spectrum_000432
TL8001323
TPI-336
UNM-0000305813
Xilebao
YM 177
YM-177
YM177
ZINC02570895
cMAP_000027
celecoxib
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
28Cyclooxygenase 2 InhibitorsPhase 1624
29
Secretinapproved, investigational31108153-74-8
Synonyms:
108153-74-8
1393-25-5
67307-60-2 (citrate (salt))
9002-77-1
EINECS 215-733-3
Hormone of the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level
Human secretin
I06-1828
L-Histidyl-L-seryl-L-alpha-aspartylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-glutamyl-L-leucyl-L-seryl-L-arginyl-L-leucyl-L-arginyl-L-alpha-aspartyl-L-seryl-L-alanyl-L-arginyl-L-leucyl-L-glutaminyl-L-arginyl-L-leucyl-L-leucyl-L-glutaminylglycyl-L-leucyl-L-valinamide
L-Histidyl-L-seryl-L-alpha-aspartylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-glutamyl-L-leucyl-L-seryl-L-arginyl-L-leucyl-L-arginyl-L-alpha-glutamylglycyl-L-alanyl-L-arginyl-L-leucyl-L-glutaminyl-L-arginyl-L-leucyl-L-leucyl-L-glutaminylglycyl-L-leucyl-L-valinamide
LS-144747
RG 1068
SECREFLO
SECRETIN
SECRETIN-FERRING
 
SecreFlow
Secrepan
Secretin (human)
Secretin (porcine)
Secretin [INN:BAN:DCF:JAN]
Secretin-Kabi
Secretina
Secretina [INN-Spanish]
Secretine
Secretine [INN-French]
Secretinum
Secretinum [INN-Latin]
Secretolin
UNII-88C55N56UU
UNII-A0426J905J
Vitrum
30
Pancrelipaseapproved97053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
31pancreatin970
32Hormone Antagonists13180
33Gastrointestinal Agents8402
34Hormones14415
35Hormones, Hormone Substitutes, and Hormone Antagonists13168
36serineNutraceutical954

Interventional clinical trials:

idNameStatusNCT IDPhase
1Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPACompletedNCT00510692Phase 2, Phase 3
2A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis PatientsCompletedNCT01187901Phase 2
3Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and EosinophiliaCompletedNCT02217332Phase 2
4Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis.Not yet recruitingNCT03061591Phase 2
5A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy VolunteersCompletedNCT00813241Phase 1
6Cancer of the Pancreas Screening Study (CAPS 3)CompletedNCT00438906
7Endocuff for Surveillance of Serrated Polyposis SyndromeRecruitingNCT02592603
8Prevalence of Small Bowel Polyps in Patients With Sporadic Duodenal AdenomasRecruitingNCT02470416
9The Cancer of the Pancreas Screening-5 CAPS5)StudyRecruitingNCT02000089
10SB3 Battery Life Observational StudyEnrolling by invitationNCT02382705

Search NIH Clinical Center for Cap Polyposis

Genetic Tests for Cap Polyposis

About this section

Anatomical Context for Cap Polyposis

About this section

MalaCards organs/tissues related to Cap Polyposis:

36
Colon

Publications for Cap Polyposis

About this section

Articles related to Cap Polyposis:

(show all 40)
idTitleAuthorsYear
1
Cap Polyposis Masquerading as Inflammatory Bowel Disease in a Child. (27437929)
2016
2
Polypectomy to eradicate cap polyposis with protein-losing enteropathy. (25287098)
2014
3
A case of cap polyposis remission by betamethasone enema after antibiotics therapy including Helicobacter pylori eradication. (24949613)
2014
4
Nine-year follow-up from onset to spontaneous complete remission of cap polyposis. (23370743)
2013
5
Cap-polyposis-like gastropathy with hypoproteinemia treated with H. pylori eradication. (24088754)
2013
6
Cap polyposis mistaken for Crohn's disease: case report and review of literature. (22766527)
2013
7
Rectal cap polyposis masquerading as ulcerative colitis with pseudopolyposis and presenting as chronic anemia: a case study with review of literature. (23828750)
2013
8
Inflammatory cap polyposis in a 42-year-old male. (23416507)
2013
9
Cap polyposis: a rare cause of rectal bleeding in children. (23864782)
2013
10
Cap polyposis and colitis cystica profunda: a rare association. (24118052)
2013
11
Long-term outcome of cap polyposis, with special reference to the effects of steroid therapy. (22078102)
2012
12
Successful management of cap polyposis with eradication of Helicobacter pylori relapsing 15 years after remission on steroid therapy. (22333383)
2012
13
Cap polyposis with protein-losing enteropathy. (21869875)
2011
14
Unusual colon polyps. Diagnosis: Cap polyposis. (21878333)
2011
15
Can the stomach be a target of cap polyposis? (20405375)
2010
16
Remission of cap polyposis maintained for more than three years after infliximab treatment. (20431770)
2009
17
Cap polyposis (CP) which relapsed after remission by avoiding straining at defecation, and was cured by Helicobacter pylori eradication therapy. (19952483)
2009
18
Hypoalbuminaemia and colonic polyps: a case of protein-losing enteropathy with cap polyposis? (17847696)
2007
19
Cap polyposis: an inflammatory disorder or a spectrum of mucosal prolapse syndrome? (16099801)
2005
20
Confined progression of cap polyposis along the anastomotic line, implicating the role of inflammatory responses in the pathogenesis. (16111972)
2005
21
Pedunculated cap polyps preceding the development of cap polyposis: case report. (15729261)
2005
22
Rectal prolapse and cap polyposis: the missing link. (15785885)
2005
23
Possible relationship between Helicobacter pylori infection and cap polyposis of the colon. (15610079)
2004
24
Cap polyposis: further experience and review. (15164251)
2004
25
Successful treatment of cap polyposis with infliximab. (15188181)
2004
26
Spontaneous resolution of cap polyposis: case report. (12665781)
2003
27
Gastrointestinal: cap polyposis. (12753160)
2003
28
Cap polyposis cured by Helicobacter pylori eradication therapy. (12108681)
2002
29
Does metronidazole cure cap polyposis by its antiinflammatory actions instead of by its antibiotic action? A case study. (12141801)
2002
30
Asymptomatic cap polyposis from the sigmoid colon to the cecum. (11677493)
2001
31
Cap polyposis of the colon and rectum: an analysis of endoscopic findings. (11293761)
2001
32
Proximal extension of cap polyposis confirmed by colonoscopy. (11522989)
2001
33
Features of cap polyposis by magnifying colonoscopy. (11115917)
2000
34
A case of "cap polyposis"-like lesion associated with ulcerative colitis: is this a case of cap polyposis? (11095366)
2000
35
Successful treatment of cap polyposis by avoidance of intraluminal trauma: clues to pathogenesis. (10950064)
2000
36
A case of cap polyposis investigated by scintigraphy with human serum albumin labeled with Tc-99m DTPA. (9712385)
1998
37
Abnormal mucus in cap polyposis. (9518233)
1998
38
Protein-losing enteropathy from cap polyposis. (7491082)
1995
39
Cap polyposis occurring in the postoperative course of pelvic surgery. (7828996)
1994
40
Cap polyposis--an unusual cause of diarrhoea. (8491408)
1993

Variations for Cap Polyposis

About this section

Expression for genes affiliated with Cap Polyposis

About this section
Search GEO for disease gene expression data for Cap Polyposis.

Pathways for genes affiliated with Cap Polyposis

About this section

GO Terms for genes affiliated with Cap Polyposis

About this section

Cellular components related to Cap Polyposis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055768.6ALB, MUC3A, MUC4, MUC5AC
2Golgi lumenGO:00057968.0MUC2, MUC3A, MUC4, MUC5AC

Biological processes related to Cap Polyposis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1maintenance of gastrointestinal epitheliumGO:00302779.7MUC2, MUC4
2O-glycan processingGO:00162668.5MUC2, MUC3A, MUC4, MUC5AC
3stimulatory C-type lectin receptor signaling pathwayGO:00022238.0MUC2, MUC3A, MUC4, MUC5AC

Molecular functions related to Cap Polyposis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular matrix constituent, lubricant activityGO:00301979.5MUC3A, MUC4
2extracellular matrix structural constituentGO:00052019.3MUC3A, MUC5AC

Sources for Cap Polyposis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet